.avif)
Webinar: Derisking a PD-L1 Targeting T-cell Engager with Preclinical Mouse Models, November 3, 2026
genOway presentation
Event
-
November 3, 2026
genOway’s live webinar
Tuesday, November 3, 2026 - 5:30 pm CET / 11:30 am EST / 8:30 am PST
Presenter: Emily Girard, Staff Scientist, James Olson Lab - Seattle Children’s Research Institute
Title: "De-risking a PD-L1 Targeting T-cell Engager with Preclinical Mouse Models"
Presentation highlights:
- A PD-L1:CD3 TCE has shown remarkable activity against intracranial xenografts in preclinical models
- genO-hPD-1/hPD-L1 mice allowed tolerability assessment of a unique PD-L1 binding protein
- genO-panhCD3 mice enabled promotion of a novel CD3 binder
Register here!
Other news & events
Scientific excellence
From model design to experimental results
Featured in 600+ scientific articles
Collaborative approach
Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions
Robust validation data on catalog models
Generated with biopharma partners and in-house
Innovative technologies
and guaranteed freedom to operate
Easy access to models
Models with certified health status from professional breeders in US and Europe